Results 111 to 120 of about 2,712,257 (268)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Saving the trees, revitalizing your coffee table and shoring up the future

BioTechniques, 2019
Francesca Lake
doaj   +1 more source

The current state of global contribution to open access publishing in neurosurgery: A bibliometric analysis. [PDF]

Brain Spine, 2023
Koester SW, Bishay AE, Batista S, Bertani R, Naik A, Haizel-Cobbina J, Isaacs A, Figueiredo EG, Paiva WS, Dewan MC.   +9 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

From industry 4.0 to lab 4.0

BioTechniques, 2019
Francesca Lake
doaj   +1 more source

Observations regarding open access publishing in hybrid journals in sport sciences. [PDF]

J Sport Health Sci, 2023
Fuchs PX, Shiang TY, Herzog W.
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

To blind or not to blind? The search for a perfect peer review methodology

BioTechniques, 2018
Francesca Lake
doaj   +1 more source

Anthropology & Open Access: An Interview with Jason Baird Jackson [PDF]

, 2011
During the last few weeks I had the chance to conduct an email based interview with Jason Baird Jackson about Open Access (OA), academic publishing, and anthropology..
Anderson, Ryan B.
core   +1 more source

10 years of open access publishing at the BIR. [PDF]

Br J Radiol, 2022
Jackson SA, Prise KM.
europepmc   +1 more source